Ownership Summary
Quarter ending 30 Jun, 2026
Ascentage Pharma Group International (NASDAQ:AAPG) appears in 8 institutional 13F filings for the quarter ending June 2026.
- These investors held 0.0% of outstanding shares in June 2026, down from 0.0% in March 2026.
- They decreased total shares held in AAPG by -10.4% quarter over quarter, and investors in Ascentage Pharma Group International decreased 33.33% from a year ago.
- Of these 8 holders, 4 added to their stakes in Ascentage Pharma Group International, 3 trimmed positions, and 1 made no changes.
- Institutional investors collectively held 15.01K shares in Ascentage Pharma Group International as of June 2026, down by 1.74K shares quarter on quarter, and down 65.81K shares year over year.
- As of June 30, 2026, the biggest holder of Ascentage Pharma Group International is Point72 Asset Management, L.P. at 13.84K shares, representing 0.02% of shares outstanding.
- Top purchasers of AAPG stock for the quarter ending June 2026 included Morgan Stanley (421), Wells Fargo & Company/Mn (200), BlackRock, Inc. (6), Caitong International Asset Management Co., Ltd (1).
- The largest sellers of Ascentage Pharma Group International for the quarter ending June 2026 were Point72 Asset Management, L.P. (2.22K), UBS Group AG (109), EverSource Wealth Advisors, LLC (47).
- According to Business Quant data, leading holders of AAPG for June 2026 are Point72 Asset Management, L.P. (13.84K), Morgan Stanley (919), Wells Fargo & Company/Mn (200), EverSource Wealth Advisors, LLC (24), UBS Group AG (15), Royal Bank Of Canada (6), BlackRock, Inc. (6), Caitong International Asset Management Co., Ltd (1).